Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 263.55B P/E 35.15 EPS this Y 1.30% Ern Qtrly Grth 472.80%
Income 5.95B Forward P/E 13.52 EPS next Y 7.20% 50D Avg Chg 8.00%
Sales 54.4B PEG 2.33 EPS past 5Y 5.57% 200D Avg Chg -1.00%
Dividend 4.00% Price/Book 19.85 EPS next 5Y 6.27% 52W High Chg -11.00%
Recommedations 2.20 Quick Ratio 0.72 Shares Outstanding 1.77B 52W Low Chg 14.00%
Insider Own 0.11% ROA 7.71% Shares Float 1.76B Beta 0.59
Inst Own 72.69% ROE 56.24% Shares Shorted/Prior 14.48M/13.12M Price 149.38
Gross Margin 69.17% Profit Margin 11.02% Avg. Volume 5,937,400 Target Price 182.41
Oper. Margin 28.29% Earnings Date Jul 25 Volume 5,753,546 Change 0.57%
About AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AbbVie Inc. News
05/17/24 Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls
05/17/24 AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
05/16/24 AbbVie CEO latest heavy hitter to buy in Boca Raton
05/16/24 Are You Looking for a High-Growth Dividend Stock?
05/15/24 NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
05/14/24 AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
05/14/24 Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
05/14/24 3 Magnificent Stocks That Are Passive Income Machines
05/13/24 12 Undervalued Stocks That Just Raised Their Dividends
05/13/24 What Is the Dividend Payout for AbbVie Stock?
05/13/24 AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
05/11/24 29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
05/11/24 Earn $1000 Every Month From These 3 Stocks
05/11/24 Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
05/10/24 Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
05/10/24 3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
05/09/24 Q1 2024 Regenxbio Inc Earnings Call
05/08/24 Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
05/08/24 QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
05/07/24 15 Best S&P 500 Dividend Stocks To Buy Now
ABBV Chatroom

User Image scottybebs Posted - 1 day ago

$ABBV all clear

User Image tkathlina Posted - 1 day ago

$ABBV $ABBV Bulls pushing 🫸 past resistance

User Image Thestocktraderhubzee Posted - 1 day ago

$ABBV Cantor Fitzgerald Initiates Coverage On AbbVie with Overweight Rating, Announces Price Target of $200

User Image katiemcdaniels96 Posted - 2 days ago

Today, I received dividends from $O $PG $ABBV. On DRIPs in my Roth. Won't have any money to reinvest in my income portfolio until I get ULTY and QDTE tomorrow. Had a great lift & run this morning. In the meantime, I'll be enjoying beautiful weather & soaking up the sunshine until I go to work tonight 🌞

User Image DefenseMania Posted - 2 days ago

I found this on NewsBreak: Earnings call: AbbVie projects robust growth and diversified pipeline $ABBV https://share.newsbreak.com/6x2ek1b9

User Image Iceman467 Posted - 2 days ago

$ABBV added 2 more. Thats right. 2 shares

User Image DefenseMania Posted - 2 days ago

$ABBV fueling like a big biotech merger is brewing $AZN + $GILD ? $AMGN $PFE

User Image StockednLoaded Posted - 2 days ago

$IOVA $ABBV paid $10.1B for $IMGN. After receiving accelerated approval to treat adv epithelial ovarian c*ncer, Elahare earned Revenues of: 1st Full Q: 46M Rev 2Q: 76M 3Q: 107M 4Q: 123M 10.1B acquisition, Trailing 348M sales = some combination of: 29x trailing 12m Sales (if you assume no value to pipeline). Iova has guided: More than 100 patients treated or enrolled in less than 3 months as well as expressed another 60 are in screening. Since approval Amtagvi has already moved to 2L Adv Melanona. Sales have been guided for MoM growth. Ignoring that and just using roughly 600 patients for first 4 full quarters and 900 patients for 2025 (conservative growth due to ex-US coming online ~Q2) 900 patients FY ‘25 * (515k + 90kproleukin), let’s assume 550k total to account for potential dropouts/discounts = $495M rev 29x those sales (if you ignore pipeline) would be 14.35B. Advanced lung 👀 1L Adv Melanoma 👀 Accretive-to-EPS 1.3B NOL 👀 20% short @3B 🤔

User Image Clargy Posted - 3 days ago

$ABBV LT breakout + rounding bottom retest

User Image MoneyTree82 Posted - 3 days ago

$CHRS a little dip and then next leg higher! Move into the 2.20’s maybe even 2.30s before close! The trend is our friend! Shorts time to close the millions of shares you have shorted! That Trade is dead! $XBI $NASDAQ $GME $ABBV

User Image DefenseMania Posted - 3 days ago

$RCUS 1hr before healthcare conference $PFE $GILD $AMGN $ABBV

User Image scottybebs Posted - 3 days ago

$ABBV room to run if we can clear $163.70

User Image Iceman467 Posted - 3 days ago

$ABBV used divvies to buy more

User Image snosrap Posted - 4 days ago

@qwertylicious2003 @JP73 https://news.abbvie.com/2020-09-28-AbbVie-Receives-Orphan-Drug-and-Fast-Track-Designations-from-the-U-S-Food-and-Drug-Administration-for-Elezanumab-an-Investigational-Monoclonal-Antibody-RGMa-Inhibitor-for-the-Treatment-of-Spinal-Cord-Injury. BD TEAM needs to lock in $ABBV for $100m

User Image Aigner_Andreas Posted - 4 days ago

#TrendFollowing #TOP10 WK 20 SELL US-BIG $AMD $IBM $ABBV $ACN $CAT ABT META MA BRK-B HD

User Image stocktrader1850 Posted - 5 days ago

$VKTX so $PFE or $MRK or $ABBV which one will partner or buy it out?

User Image Stock_Titan Posted - 5 days ago

$ABBV AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders https://www.stocktitan.net/news/ABBV/abb-vie-and-gilgamesh-pharmaceuticals-announce-collaboration-and-aee3ajduc98x.html

User Image katiemcdaniels96 Posted - 6 days ago

Hope everyone had a wonderful Mother's Day! I enjoyed my time with family 🥰 This upcoming week, I'll be expecting payments from $ABBV $O $PG $AAPL in my Roth! All on DRIPS.

User Image DefenseMania Posted - 6 days ago

$RCUS will present on May 16th $ABBV $PFE $GILD https://finance.yahoo.com/news/arcus-biosciences-participate-bank-america-200500872.html

User Image Simon77 Posted - 1 week ago

$ABBV whales are loading hard. Get ready for WS pump 🚀

User Image Kingjake26 Posted - 1 week ago

@Jumpytermite so sorry I upset you but I can understand your frustration. Yes it has been a bumpy road but I do believe in the products and the 2400 people that had been treated with R. FDA is a mind of its own. I believe with the big company $abbv we will do well . So sorry. Hope you have a great weekend

User Image Wrenster35 Posted - 1 week ago

$ABBV short it Jim Lebenthal owns it

User Image PrecisionSwingTrader Posted - 1 week ago

TRADE CLOSED Symbol: $BMY Type: Sell to Close Intraday (Held Overnights) Return: +1.5% (67-cents) Entry: 4/25/2024 Avg Price: 43.96 Exit: 44.63 Size: 10% Rationale: I entered this originally as a day trade as price collapsed into major, multi-year support. I did not get the intraday bounce I wanted (obviously), but since price was into such a major level, I held. This position at one point was up to 50% of my portfolio (using margin), as I was trading 15- to 25-cent intraday moves each day to bring down my avg price / cost basis. Daily chart shorts a mature bear flag, so the fact we got the pop yesterday was a relief honestly, because probabilities were against me. I set my stop tight to just under consolidation, but the weird flush candle triggered the stop. In summary: got lucky & I know it. $PFE $GILD $AMGN $ABBV

User Image Simon77 Posted - 1 week ago

$ABBV looks like some news released. Huge block buy orders. Pile in 🚀

User Image Simon77 Posted - 1 week ago

$ABBV bull flagging on the wkly, bouncing off the 50ma. Start a long position and wait for the pop and continuation.

User Image Zaylo12918 Posted - 1 week ago

$ABBV this is looking good!

User Image Simon77 Posted - 1 week ago

$ABBV bounced off weekly /hourly trend line. Consolidation is over, go long. 🚀

User Image stvvvvvks Posted - 1 week ago

$ABBV who tf loaded 1100+ deep ITM puts for next week? Check the 175p 🤔

User Image DarkMandalorian Posted - 1 week ago

$ABBV Cheap value here $SPY $QQQ

User Image Simon77 Posted - 1 week ago

$ABBV big money is loading, anything in the $160s is a buy

Analyst Ratings
Cantor Fitzgerald Overweight May 17, 24
Barclays Overweight Apr 29, 24
BMO Capital Outperform Apr 29, 24
Barclays Overweight Mar 27, 24
Guggenheim Buy Mar 22, 24
Truist Securities Buy Feb 6, 24
Raymond James Outperform Feb 6, 24
BMO Capital Outperform Feb 5, 24
Raymond James Outperform Feb 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Donoghoe Nicholas EVP, CHIEF BUS/STRAT.. EVP, CHIEF BUS/STRAT OFFICER Dec 26 Sell 154.72 2,912 450,545 55,903 12/28/23
GONZALEZ RICHARD A CHAIRMAN OF THE BOAR.. CHAIRMAN OF THE BOARD AND CEO Jul 31 Sell 148.87 78,500 11,686,295 565,294 08/02/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Apr 17 Sell 161.84 7,499 1,213,638 35,330 04/19/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 28 Sell 155 15,003 2,325,465 42,829 03/02/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 28 Option 93.5 15,003 1,402,780 57,832 03/02/23
Siatis Perry C EVP, GC AND SECRETAR.. EVP, GC AND SECRETARY Feb 28 Sell 153.22 12,135 1,859,325 10,377 03/02/23
Strom Carrie C SVP & PRES GLOBAL AL.. SVP & PRES GLOBAL ALLERG AESTH Feb 16 Sell 151.02 28,541 4,310,262 37,921 02/21/23
Strom Carrie C SVP & PRES GLOBAL AL.. SVP & PRES GLOBAL ALLERG AESTH Feb 16 Option 62.09 14,179 880,374 66,462 02/21/23
SALEKI-GERHARDT AZITA EVP, OPERATIONS EVP, OPERATIONS Feb 16 Option 51.42 25,000 1,285,500 258,208 02/21/23
SALEKI-GERHARDT AZITA EVP, OPERATIONS EVP, OPERATIONS Feb 16 Sell 149.59 25,000 3,739,750 233,208 02/21/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 16 Sell 151.02 15,321 2,313,777 62,679 02/21/23
Sorg Elaine K. SVP, US COMMERCIAL O.. SVP, US COMMERCIAL OPERATIONS Feb 16 Option 105.92 15,321 1,622,800 78,000 02/21/23
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Option 104.59 79,801 8,346,387 231,904 05/25/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 23 Sell 151.16 79,801 12,062,719 152,103 05/25/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Option 54.86 83,960 4,606,046 125,583 05/20/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer May 16 Sell 155 83,960 13,013,800 41,623 05/20/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Option 78.23 200,000 15,646,000 252,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 16 Sell 154.58 200,000 30,916,000 152,103 05/18/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Sell 151.2 300,000 45,360,000 152,103 05/10/22
SEVERINO MICHAEL Vice Chairman Vice Chairman May 06 Option 57.21 300,000 17,163,000 252,103 05/10/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Option 58.88 27,690 1,630,387 88,631 03/25/22
Stewart Jeffrey Ryan EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 24 Sell 159.2 27,690 4,408,248 60,941 03/25/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Option 79.02 11,682 923,112 37,722 03/11/22
Durkin Brian L VP, Controller VP, Controller Mar 09 Sell 150 18,628 2,794,200 19,094 03/11/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Mar 01 Sell 148.12 25,000 3,703,000 16,623 03/02/22
Gosebruch Henry O EVP, Chief Strategy.. EVP, Chief Strategy Officer Feb 25 Sell 148.43 15,000 2,226,450 41,623 03/01/22
Michael Robert A. Vice Chairman Vice Chairman Feb 25 Sell 148.32 43,105 6,393,334 37,877 03/01/22
Strom Carrie C SVP & Pres Global Al.. SVP & Pres Global Allerg Aesth Feb 07 Sell 141.17 2,396 338,243 42,499 02/08/22
AUSTIN ROXANNE S Director Director Nov 02 Sell 116.42 71,844 8,364,078 49,284 11/04/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Sell 120 13,080 1,569,600 11,595 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Aug 25 Option 114.36 7,080 809,669 18,675 08/25/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Option 86.26 20,195 1,742,021 52,946 02/24/21
Sorg Elaine K. SVP, US Commercial O.. SVP, US Commercial Operations Feb 24 Sell 105 20,195 2,120,475 32,751 02/24/21
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Option 51.42 51,990 2,673,326 51,990 12/01/20
RICHMOND TIMOTHY J. EVP, Chief HR Office.. EVP, Chief HR Officer Dec 01 Sell 105 51,990 5,458,950 12/01/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Option 24.21 4,800 116,208 118,667 11/12/20
SALEKI-GERHARDT AZITA EVP, Operations EVP, Operations Nov 12 Sell 93.61 4,800 449,328 113,867 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Option 56.87 194,154 11,041,538 512,796 11/12/20
GONZALEZ RICHARD A Chairman of the Boar.. Chairman of the Board and CEO Nov 12 Sell 96.76 231,604 22,410,003 318,642 11/12/20